Abstract
This work was undertaken to examine the effect of cyclosporine A (CyA) on the serum concentration of circulating immune complexes in 22 patients with IgA nephropathy during an infection-free period. They were randomly divided into 2 groups: 11 patients received oral cyclosporine A (5 mg/kg/day) for 12 weeks and 11 patients received placebo (0.05 ml/kg/day). A significant reduction of proteinuria was observed in patients on CyA therapy but not in those receiving placebo. IgG-circulating immune complexes (CIC) were determined by solid phase Clq enzyme immunoassay (Clq EIA) and radial immunodiffusion (RID) and IgA-CIC were determined by solid phase anti-C3 enzyme immunoassay (anti-C3 EIA) and radial immunodiffusion. There was no change in IgA-CIC measured by RID and anti-C3 EIA after 12 weeks of CyA therapy. Similarly, changes in IgG-CIC were not demonstrated with CyA therapy. No apparent decrease in IgG-CIC or IgA-CIC was observed with placebo treatment. Our study suggests that immunomodulation by CyA therapy does not affect the IgA-CIC and IgG-CIC levels in patients with IgA nephropathy.
Similar content being viewed by others
References
D’Amico, G.: The commonest glomerulonephritis in the world: IgA nephropathy.Q. J. Med., 64, 709 (1987).
Woodroffe, A. J., Gormly, A. A., McKenzie, P. E., Wooton, A. M., Thompson, A. J., Seymour, A. E., Clarkson, A. R.: Immunologic studies in IgA nephropathy.Kidney Int., 18, 366 (1980).
Coppo, R., Basolo, B., Martina, G., Rollino, C., De Marchi, M., Giacchino, F., Mazzucco, G., Piccoli, G.: Circulating immune complexes containing IgA, IgG and IgM in patients with primary IgA nephropathy and with Henoch-Schoenlein nephritis. Correlation with clinical and histologic signs of activity.Clin. Nephrol., 19, 230 (1982).
Egido, J., Sancho, J., Rivera, F., Hernando, L.: The role of IgA and IgG immune complexes in IgA nephropathy.Nephron, 36, 52 (1984).
Czerkinsky, C., Koopman, W. J., Jackson, S., Collins, J. E., Crago, S. S., Schrohenloher, R. D., Julian, B. A., Galla, J. H., Mestecky, J.: Circulating immune complexes and immunoglobulin A rheumatoid factor in patients with mesangial immunoglobulin A nephropathies.J. Clin. Invest., 77, 1931 (1986).
Hall, R. P., Stachura, I., Cason, J., Whiteside, T. L., Lawley, T. J.: IgA containing circulating immune complexes in patients with IgA nephropathy.Am. J. Med., 74, 56 (1983).
Hess, A. D., Tutschka, P. J., Pu, Z., Santos, G. W.: Effect of cyclosporin A on human lymphocyte response in vitro. IV. Production of T cell stimulatory growth factors and development of responsiveness to these growth factors in CyA-treated primary MLR cultures.J. Immunol., 128, 360 (1982).
Tipping, P. G., Holdsworth, S. R.: Effect of cyclosporin A on antibody-induced experimental glomerulonephritis.Nephron, 40, 201 (1985).
Gunn, H. C., Ryffel, B.: Glomerulonephritis in NZB/W mice: therapeutic effect of cyclosporine.Clin. Nephrol., 25, S189 (1986).
Lai, K. N., Chui, S. H., Lai, F. M., Lam, C. W. K.: Predominant synthesis of IgA with lambda light chain in IgA nephropathy.Kidney Int., 33, 584 (1988).
Mobray, J. F.: Detection of circulating immune complexes. In: Skerrow, D., Skerrow, C. J. (eds): Methods in Skin Research. John Wiley & Sons, London 1985, pp. 175–190.
Imai, H., Chen, A., Wyatt, J. R., Rifai, A.: Composition of IgA immune complexes precipitated with polyethylene glycol.J. Immunol. Methods, 103, 239 (1987).
Lai, K. N., Lai, F. M., Vallance-Owen, J.: A short-term controlled trial of Cyclosporine A in IgA nephropathy.Transplant. Proc., 20, 297 (1988).
Lawrence, S., Pussell, B. A., Charlesworth, J. A.: Mesangial IgA nephropathy: detective reticulophagocytic function in vivo.Clin. Nephrol., 16, 280 (1983).
Egido, J., Blasco, R., Sancho, J., Lozano, L.: T-cell dysfunction in IgA nephropathy: specific abnormalities in the regulation of IgA synthesis.Clin. Immunol. Immunopathol., 26, 201 (1983).
Hernando, L., Egido, J., de Nicolas, R., Sancho, J.: Clinical significance of polymeric and monomeric IgA complexes in patients with IgA nephropathy.Am. J. Kidney Dis., 8, 410 (1986).
Davin, J. C., Foidart, J. B., Mahieu, P. R.: Relation between biological IgA abnormalities and mesangial IgA deposits in isolated hematuria in children.Clin. Nephrol., 28, 73 (1987).
Meyrier, A., Simon, P., Perret, G., Condamin-Meyrier, M.: Remission of idiopathic nephrotic syndrome after treatment with cyclosporin A.Br. Med. J., 292, 789 (1986).
Hale, G. M., McIntosh, S., Hiki, Y., Clarkson, A. R., Woodroffe, A. J.: Evidence for IgA-specific B cell hyperactivity in patients with IgA nephropathy.Kidney Int., 29, 718 (1986).
Lai, K. N., Lai, F. M., Chui, S-H., Leung, K. N., Lam, C. W. K.: Effect of cyclosporin on lymphocyte subpopulations and immunoglobulin production in IgA nephropathy.Nephron, 52, 307 (1989).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Lai, K.N., Lam, C.W.K., Cheng, I.K.P. et al. Effect of cyclosporine a on circulating immune complexes in IgA nephropathy. International Urology and Nephrology 23, 265–274 (1991). https://doi.org/10.1007/BF02550423
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02550423